Your browser doesn't support javascript.
loading
Inflammatory bowel disease events after exposure to interleukin 17 inhibitors secukinumab and ixekizumab: Postmarketing analysis from the RADAR ("Research on Adverse Drug events And Reports") program.
Orrell, Kelsey A; Murphrey, Morgan; Kelm, Ryan C; Lee, Harrison H; Pease, David R; Laumann, Anne E; West, Dennis P; Nardone, Beatrice.
Affiliation
  • Orrell KA; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Murphrey M; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Kelm RC; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Lee HH; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Pease DR; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Laumann AE; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • West DP; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Nardone B; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: b-nardone@northwestern.edu.
J Am Acad Dermatol ; 79(4): 777-778, 2018 Oct.
Article in En | MEDLINE | ID: mdl-29920313

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Adverse Drug Reaction Reporting Systems / Antibodies, Monoclonal, Humanized / Antibodies, Monoclonal Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: America do norte / Oceania Language: En Journal: J Am Acad Dermatol Year: 2018 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Adverse Drug Reaction Reporting Systems / Antibodies, Monoclonal, Humanized / Antibodies, Monoclonal Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: America do norte / Oceania Language: En Journal: J Am Acad Dermatol Year: 2018 Document type: Article Country of publication: United States